GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pet Pharm Biotech Co Ltd (ROCO:7762) » Definitions » YoY EPS Growth

Pet Pharm Biotech Co (ROCO:7762) YoY EPS Growth : 106.87% (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Pet Pharm Biotech Co YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Pet Pharm Biotech Co's YoY EPS Growth for the quarter that ended in Dec. 2024 was 106.87%.

Pet Pharm Biotech Co's Earnings per Share (Diluted) for the six months ended in Dec. 2024 was NT$0.27.

Pet Pharm Biotech Co YoY EPS Growth Historical Data

The historical data trend for Pet Pharm Biotech Co's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pet Pharm Biotech Co YoY EPS Growth Chart

Pet Pharm Biotech Co Annual Data
Trend Dec22 Dec23 Dec24
YoY EPS Growth
- 294.97 16.13

Pet Pharm Biotech Co Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24
YoY EPS Growth - - - -50.28 106.87

Pet Pharm Biotech Co YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Pet Pharm Biotech Co's YoY EPS Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EPS Growth (A: Dec. 2024 )
=(Earnings per Share (Diluted) (A: Dec. 2024 )-Earnings per Share (Diluted) (A: Dec. 2023 ))/ | Earnings per Share (Diluted) (A: Dec. 2023 ) |
=(0.36-0.31)/ | 0.31 |
=16.13 %

Pet Pharm Biotech Co's YoY EPS Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EPS Growth (Q: Dec. 2024 )
=(Earnings per Share (Diluted) (Q: Dec. 2024 )-Earnings per Share (Diluted) (Q: Dec. 2023 )) / | Earnings per Share (Diluted) (Q: Dec. 2023 )) |
=(0.271-0.131)/ | 0.131 |
=106.87 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pet Pharm Biotech Co YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Pet Pharm Biotech Co's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Pet Pharm Biotech Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pet Pharm Biotech Co Ltd (ROCO:7762) » Definitions » YoY EPS Growth
Comparable Companies
ROCO:6130 ROCO:4102 LLY JNJ ABBV OCSE:NOVO B XSWX:ROG XSWX:NOVN LSE:AZN MRK AMGN PFE GILD XPAR:SAN BMY TSE:4519 LSE:GSK TSE:4568 SHSE:600276 XTER:BAYN
Traded in Other Exchanges
N/A
Address
143, Hougang 1st Road, 1-2F., No. 141, Xinzhuang District, New Taipei City, TWN, 242051
Website
https://www.petpharmbio.com
Pet Pharm Biotech Co Ltd is a Pharmaceutical company. The company is engaged in manufacturing medicinal products and medicine drugs. The products offered by the company include FDG Fluodeoxyglucose Injection (18F-FDG), Naolixi Injection (18F-FBB), Sodium fluoride injection (18F-NaF), and others.

Pet Pharm Biotech Co Headlines

No Headlines